NYSE : ATS
$0.45 (1.68%)
NYSE
Douglas William Wright
Industrial - Machinery
Industrials
ATS
7000
CA
USD
0.81
1.64
1.36
0.27
0.00
$2.97B
1.25
2.11
9.46
4.00
$0.73
$71.64M
2.41%
3.34%
4.08%
1.65%
51.69
0.02
0.02
$34.00
$34.00
$34.00
2/5
3 Analysts
-19.88%
2.13
7/9
$668.2M
$4.34B
$2.56B
$203.64M
$4.86B
1.64
13.59
1.64
4.08%
4.74%
1.91%
10.57%
$17.26
66 days
| Name | Title |
|---|---|
| David Ocampo | Head of Investor Relations |
| Gordon G. Raman | Chief Legal Officer |
| Sarah Moore | Group Executive of Life Sciences |
| Jeffrey Adamson | Chief Information Officer |
| Miroslav Kafedzhiev | President of Industrial Automation |
| Giuseppe Tassone | Vice President of Mergers & Acquisitions |
| Douglas William Wright | Chief Executive Officer & Director |
| Simon Roberts | President of Packaging & Food Technology |
| Steve Emery | Senior Vice President of ATS Business Model |
| Angella V. Alexander | Chief Human Resources Officer |
| Anne Cybulsk | Interim CFO, VP & Corporate Controller |
No votes yet today — be the first to share your view!
About ATS Corporation (NYSE:ATS) Stock
ATS Corporation is a global provider of comprehensive automation solutions, specializing in the entire lifecycle of automated manufacturing and assembly systems. From initial planning, design, and engineering through to building, commissioning, and ongoing servicing, the company supports clients worldwide. Their extensive offerings include a wide array of automation products and advanced test solutions. Pre-automation services involve critical activities such as discovery and analysis, concept development, simulation, and total cost of ownership modeling. Post-automation support is equally robust, encompassing client training, process optimization, preventative maintenance, emergency and on-call assistance, spare parts, retooling, retrofits, and equipment relocation. Beyond these, ATS deli ... vers contract manufacturing services, after-sales support, and specialized engineering expertise covering prototyping, process verification, specification writing, software and manufacturing process controls development, standard automation products/platforms, equipment design and build, third-party equipment qualification, procurement and integration, system installation, product line commissioning, validation, and documentation. They also provide value engineering, supply chain management, and comprehensive integration and manufacturing capabilities. A significant part of their offering includes advanced software and digital solutions, notably connected factory floor management systems. These systems are designed to capture, analyze, and leverage real-time machine performance data to diagnose issues, enhance processes and products, prevent operational downtime, boost efficiency, and ultimately drive sustainable production improvements. ATS serves a diverse range of industries, including life sciences, transportation and mobility, consumer products, food and beverage, electronics, nuclear, packaging, warehousing and distribution, and energy sectors. Founded in 1978 and headquartered in Cambridge, Canada, the company was formerly known as ATS Automation Tooling Systems Inc. before rebranding as ATS Corporation in November 2022.
Earnings Preview: ATS (ATS) Q1 Earnings Expected to Decline
2026-07-30 11:01:53
ATS (ATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ATS Announces Dates of First Quarter Results Conference Call and Annual Meeting of Shareholders
2026-07-23 19:00:00
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) will report its financial results for the first quarter ended June 28, 2026, before markets open on Thursday August 06, 2026. At 8:30 a.m. Eastern on August 06, 2026, the Company will host a conference call and webcast of management's quarterly remarks and follow up question and answer period with analysts. The listen-only webcast can be accessed at https://events.q4inc.com/attendee/766230709 an.
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS
2026-06-30 10:00:00
[url="]Interactive Brokers[/url] (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea
New Strong Sell Stocks for June 29th
2026-06-29 06:11:05
ATS, BXBLY and SKY have been added to the Zacks Rank #5 (Strong Sell) List on June 29, 2026.
Implied Volatility Surging for ATS Corporation Stock Options
2026-06-22 11:55:32
Investors need to pay close attention to ATS stock based on the movements in the options market lately.
Fusemachines Expands Access to Agentic AI for Talent Acquisition Through Broad ATS Connectivity
2026-06-18 08:30:00
NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Fusemachines Inc. (NASDAQ: FUSE), a leading provider of enterprise AI products and services, today announced expanded enterprise access to its Agentic AI for Talent Acquisition platform through new connectivity with more than 30 enterprise applicant tracking systems (ATS), enabling Fusemachines Agents to work directly within the systems organizations already use to manage talent and hiring. This expanded connectivity represents the first in a broader series of planned platform enhancements designed to bring AI-powered recruiting capabilities closer to the workflows, data, and systems recruiters rely on every day.
New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF
2026-06-18 04:05:00
Not intended for UK and US audiences Nerandomilast long-term survival modeling presented at American Thoracic Society (ATS) 2026 and European Alliance of Associations for Rheumatology (EULAR) 2026 international congresses. Based on the modeling, nerandomilast consistently increased median survival in both idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).1,2 Modeling predicts meaningful extensions in survival with nerandomilast, including a multi-year increase in median survival when used as monotherapy, and additional gains when added to standard treatment.1,2 Ingelheim, Germany - Long-term survival modeling of Boehringer Ingelheim's oral preferential PDE4B inhibitor, nerandomilast, predicts the therapy could extend survival by up to 5.4 years in adults with idiopathic pulmonary fibrosis (IPF) and up to 3.3 years in adults with progressive pulmonary fibrosis (PPF), compared with no therapy.1,2 These findings are based on data from the Phase III FIBRONEER™ trials and were recently presented at the ATS and EULAR 2026 international congresses.
New Strong Sell Stocks for June 15th
2026-06-15 04:36:09
ATS, BFC and CMC have been added to the Zacks Rank #5 (Strong Sell) List on June 15, 2026.
Frequently Asked Questions
What is the current ATS Corporation (ATS) stock price?
ATS Corporation(NYSE:ATS) stock price is $27.24 in the last trading session. During the trading session, ATS stock reached the peak price of $35.82 while $23.85 was the lowest point it dropped to. The percentage change in ATS stock occurred in the recent session was 1.68% while the dollar amount for the price change in ATS stock was $0.45.
ATS's industry and sector of operation?
The NYSE listed ATS is part of Industrial - Machinery industry that operates in the broader Industrials sector.
Who are the executives of ATS?
David Ocampo
| Head of Investor Relations
Gordon G. Raman
| Chief Legal Officer
Sarah Moore
| Group Executive of Life Sciences
Jeffrey Adamson
| Chief Information Officer
Miroslav Kafedzhiev
| President of Industrial Automation
How many employees does ATS have?
Number of ATS employees currently stands at 7000. ATS operates from Building No.2, Cambridge, ON N3H 4R7, CA.
Link for ATS official website?
Official Website of ATS is: https://www.atsautomation.com
How do I contact ATS?
ATS could be contacted at phone #519 653 6500 and can also be accessed through its website. ATS operates from Building No.2, Cambridge, ON N3H 4R7, CA.
How many shares of ATS are traded daily?
The average number of ATS shares traded daily for last 3 months was 173.33K.
What is the market cap of ATS currently?
The market value of ATS currently stands at $2.67B with its latest stock price at $27.24